“It’s not supposed to be easy. Anyone who finds it easy is stupid.”
‍— Charlie Munger

Investing looks deceptively simple: buy a piece of a great business for less than it is worth and let time do the work. The difficulty lies in the execution—identifying what actually constitutes a great business, developing a reasonable estimate of its value, recognizing when the market is mispricing it, and maintaining the conviction to act.

Stock picking is frequently thought of as an information game. Read more reports. Build more complex models. Track more data. While these efforts help, more information alone does not make someone a better investor. The harder part is judgment: knowing which signals actually matter, distinguishing signal from noise, and having the discipline to wait until the odds tilt meaningfully in your favor.

Charlie Munger framed stock picking not as a standalone discipline, but as an extension of what he called “worldly wisdom.” His argument was that facts alone are not enough. They become useful only when they fit into a framework of mental models drawn from multiple disciplines.

Before you can become a great stock picker, you have to become a better thinker.

Seeing Past the Scoreboard

Munger called this framework a “latticework” of mental models. Business reality cannot be understood through finance alone. If you look at the world only through the lens of finance or accounting, you become like the proverbial man with a hammer who treats every problem like a nail.

Understanding a business requires drawing on ideas from multiple disciplines—as varied as economics, psychology, mathematics, history, engineering, technology, and the natural sciences, including physics, chemistry, and biology. Which models matter most depends on the nature of the business and the forces driving its performance.

Take competitive advantage, for example. Economics may explain how scale lowers unit costs and improves purchasing power, while psychology may explain why customers gravitate toward familiar products or trusted suppliers. Competitive dynamics determine how difficult it is for a new entrant to replicate an established business, while reinvestment can strengthen that advantage further as higher cash flows fund better products, more R&D, and broader capabilities. The insight rarely comes from any one model in isolation, but from understanding how several forces interact and reinforce one another.

Looking only at financial statements shows you the scoreboard—the numerical outcome of what has already happened. They tell us what a business has earned, but not necessarily why it earned those returns or whether it will continue to do so. The real work begins when we move from observing the results to understanding the interplay of forces that produced them—and whether those forces will endure.

What Makes a Business Hard to Displace?

One of the most important questions in evaluating a business is deceptively simple: Why should it continue to earn attractive returns? The answer lies in understanding what protects its competitive position and makes those returns sustainable.

In consumer businesses, the answer may be familiar: brand, distribution, habit, scale, or customer loyalty. In many of the B2B industries we invest in, however, competitive advantage is less visible and often built gradually over long periods of time.

A pharmaceutical company may spend years qualifying a supplier for a particular molecule or process. A specialty chemical customer may depend on a vendor whose product has been qualified and validated within its manufacturing system. A CDMO may accumulate years of process knowledge around a customer's molecule, regulatory filings, analytical methods, and manufacturing conditions.

Once those relationships become embedded, changing suppliers is no longer simply a matter of finding someone willing to charge a lower price. A customer must consider whether the new supplier can consistently meet specifications, how long qualification will take, whether regulatory filings need to be amended, whether production could be disrupted, and what happens if the new vendor fails.

All of that creates friction, and friction can create economic value.

Pricing power in B2B businesses often looks very different from pricing power in consumer brands. It does not always mean large price increases. It can appear in the ability to preserve margins, pass through higher input costs, or resist replacement by a lower-priced competitor. A specialized component may represent a small fraction of the customer's total product cost, yet its failure could disrupt an entire production process. The potential savings from switching suppliers may simply not justify the associated risks.

In many of the businesses we invest in, competitive advantage is accumulated rather than invented. It is built through a trained workforce, successful regulatory and customer audits, process knowledge gained from serving diverse customers, specialized equipment, deep customer relationships, and the ability to solve problems when something goes wrong. None of these capabilities may look extraordinary on its own. Together, they can make a business remarkably difficult to displace.

We favor management teams that reinvest behind their competitive advantages. A specialized CDMO, for example, can use the process knowledge and customer relationships developed through existing projects to add adjacent capabilities, expand into more complex chemistry, and pursue larger commercial manufacturing opportunities. When that additional capital earns attractive returns, the business has the potential to compound earnings for many years.

A useful way to test a competitive advantage is to invert the question. Instead of asking only how a company can continue to win, consider what might cause it to lose. What would make a customer switch? What would allow a competitor to enter? What could erode the economics that appear so attractive today?

*Thinking in Bets

Finding a great business is only half the equation. The other half is what you pay for it.

Charlie Munger compared the stock market to a pari-mutuel betting system at a racetrack. Everyone at the track can read the racing form and recognize that one horse is clearly superior to another. But everyone else can see it too, and the odds adjust accordingly. The best horse may pay only 3-to-2 while an obviously inferior horse pays 100-to-1. Once price enters the equation, the better horse is not necessarily the better bet.

The stock market works much the same way. It is not enough to identify a business with formidable switching costs, specialized capabilities, and a strong execution track record. The market is rarely blind to quality, and exceptional businesses often command exceptional valuations. The investor must therefore ask what expectations about future performance are already embedded in the price. A great company and a great investment are not necessarily the same thing.

This is also where false precision can become dangerous. A company's value cannot be known to an exact number because the future depends on too many variables—growth, margins, competition, reinvestment, management decisions, and the cost of capital among them. A detailed spreadsheet can create the illusion of certainty simply because the answer is expressed precisely. The objective is not to forecast every variable perfectly. It is to be approximately right about the variables that matter and determine whether the price provides enough room for inevitable errors in judgment.

Investment opportunities arise when market expectations diverge meaningfully from the long-term prospects of a business. In the kinds of B2B companies we study, that can happen because the market sometimes underestimates the value of relationships and capabilities that take years to build.

Consider a CDMO experiencing a delay in a customer's clinical program or a specialty chemical company going through an inventory destocking cycle. Reported earnings may weaken even though the underlying customer relationships, technical capabilities, and qualification barriers remain largely intact. In such cases, financial performance can deteriorate before the competitive position does.

Of course, not every decline is temporary. Sometimes weak earnings are the first indication that the underlying economics are deteriorating. A competitor may have developed a superior process, a customer may be moving away, or technology may be making an established capability less valuable. The task is not to explain away disappointing results, but to understand what caused them and whether the change is temporary or structural.

In the absence of a meaningful gap between price and value, there is little reason to act. The work continues—deepening our understanding of the business, testing the durability of its competitive advantage, and refining our estimate of value.

The purpose of all that work is not to produce more trades. It is to recognize those occasions when short-term concerns have affected the stock price far more than they have changed the long-term value of the business.

Such opportunities are rare and often emerge when the news is unpleasant and buying feels uncomfortable. But when the underlying economics are well understood and the price materially understates long-term value, the research done beforehand provides the basis for acting with conviction.

Research Beyond the Portfolio

The paradox of stock picking is that doing it well requires enormous amounts of work but surprisingly little investment activity. We study businesses across industries, often without any immediate intention to invest. This builds a body of knowledge, provides valuable comparisons, and helps us recognize patterns across different businesses.

The knowledge accumulates, but the investable opportunity set is usually much smaller than the research universe. Only occasionally do business quality, our understanding of it, and an attractive price come together. When they do, much of the groundwork necessary to act has already been done.

The work is continuous; the opportunities are not.

---

*The heading “Thinking in Bets” is a nod to Annie Duke’s book of the same name.